4
Changes in Ownership
BIODESIX INC Filed Acc 0001140361-22-018734
Chief Scientific Officer sold 2,004 shares at $1.83 ($3,667)
- Chief Scientific Officer acquired 5,647 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Georgantas Robert William III · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-09 | Exercise or conversion : show line 1 in the form | +5,647 | 20,287 | D | ||
| 2022-05-10 | Sale : show line 2 in the form | −2,004 | $1.83 | $3,667 | 18,283 | D |
| Open-market sales · 2,004 sh · avg $1.83 · $3,667 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-05-09 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,971 | 1,971 | 29,566 | D |
| 2022-05-09 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −3,676 | 3,676 | 18,377 | D |
Loading xslF345X03/form4.xml…